secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2025-07-25T23:59:59+00:00
Accession:  0001493152-25-011402
Event type: regulatory
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Daré Bioscience regains Nasdaq compliance but faces one-year Mandatory Panel Monitor
--------------------------------------------------------------------------------

- Received Nasdaq letter confirming compliance with stockholders' equity rule (Nasdaq 5550(b)(1)) on July 24, 2025.
- Subject to Mandatory Panel Monitor for one year from July 24, 2025.
- If non-compliance within year, delist determination with no right to submit compliance plan or cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315225011402/0001493152-25-011402-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315225011402/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011402

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer